Balyasny Asset Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.3M | Sell |
|
|||||
|
2025
Q1 | $10.8M | Sell |
|
|||||
|
2024
Q4 | $26.9M | Buy |
|
|||||
|
2024
Q3 | $15.4M | Buy |
|
|||||
|
2024
Q2 | $7.78M | Buy |
|
|||||
|
2024
Q1 | $5.19M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $26.6K | Sell |
|
|||||
|
2022
Q3 | $2.22M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $3.11M | Sell |
|
|||||
|
2020
Q4 | $4.53M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $938K | Buy |
|
|||||
|
2019
Q1 | $780K | Sell |
|
|||||
|
2018
Q4 | $640K | Buy |
|